Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 38Neoplasm Metastasis 9Brain Neoplasms 6Stomach Neoplasms 3Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Neoplasms 2Neoplasm, Residual 2Meningeal Carcinomatosis 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Cancer With Brain Metastasis 2Advanced Breast Cancer 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Ovarian Neoplasms 1Inflammatory Breast Neoplasms 1HER2-positive Breast Cancer 1HER2-negative Breast Cancer 1HER2 Overexpression 1Glioblastoma 1Gastric Adenocarcinoma 1Drug-Related Side Effects and Adverse Reactions 1Colonic Neoplasms 1Breast Cancer Metastatic 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 7Etoposide 6Amifostine 6Radiotherapy 5Drug Therapy 5Cyclophosphamide 5apatinib 4Methotrexate 4Filgrastim 4Cytarabine 4sodium thiosulfate 3Methylprednisolone 3Carboplatin 3pegfilgrastim 2glucarpidase 2etoposide phosphate 2Voriconazole 2Vincristine 2Social Determinants of Health 2Pyridoxine 2Nivolumab 2Gemcitabine 2Doxorubicin 2Docetaxel 2Chemotherapy, Adjuvant 2Capecitabine 2trastuzumab deruxtecan 1selinexor 1sargramostim 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Drug-Related Side Effects and Adverse Reactions × trastuzumab deruxtecan × Clear all
NCT07582887 2026-05-13

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental

Recruiting
70 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡